Vivo Bio Tech Ltd.
| BSE: 511509 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE380K01017 |
| BSE 14:04 | 20 May | 39.00 |
0.15 (0.39%) |
OPEN
39.00 |
HIGH
40.00 |
LOW
38.25 |
| NSE 05:30 | 01 Jan | Vivo Bio Tech Ltd Not listed in NSE |
| OPEN | 39.00 |
| PREVIOUS CLOSE | 38.85 |
| VOLUME | 2774 |
| 52-Week high | 115.10 |
| 52-Week low | 36.45 |
| P/E | 18.22 |
| Mkt Cap.(Rs cr) | 58 |
| Buy Price | 39.00 |
| Buy Qty | 31.00 |
| Sell Price | 39.90 |
| Sell Qty | 1990.00 |
About Vivo Bio Tech Ltd.
Vivo Bio Tech Ltd
Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD AAALAC & IND guidelines. The company offers services in the areas of In vitro In vivo toxicity studies pharmacological investigations pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining d...> More
Vivo Bio Tech Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
58 | |
| EPS - TTM | () |
[*S] | 2.14 |
| P/E Ratio | (X) | [*S] | 18.22 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 32.62 |
| P/B Ratio | () |
[*S] | 1.20 |
Announcement
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disc
-
Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
Vivo Bio Tech Ltd - Financial Results
Particulars ( cr) |
Dec 2021 | Dec 2020 | % Chg |
| Net Sales | 12.92 | 11.87 | 8.85 |
| Other Income | - | ||
| Total Income | 12.92 | 11.87 | 8.85 |
| Total Expenses | 7.17 | 7.09 | 1.13 |
| Operating Profit | 5.75 | 4.78 | 20.29 |
| Net Profit | 1.37 | 2.23 | -38.57 |
| Equity Capital | 14.2 | 12.89 | - |
Vivo Bio Tech Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Medi Caps | 53.50 | 2.49 | 66.71 |
| Sandu Pharma. | 74.35 | 0.95 | 65.50 |
| Auro Labs. | 96.05 | 0.52 | 59.84 |
| Vivo Bio Tech | 39.00 | 0.39 | 58.03 |
| Ind-Swift | 10.57 | 0.28 | 57.24 |
| Source Natural | 87.70 | -2.56 | 56.48 |
| Vineet Laborator | 57.90 | 2.30 | 53.38 |
Vivo Bio Tech Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherVivo Bio Tech Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -0.26% | NA | 2.48% | 2.66% |
| 1 Month | -11.46% | NA | -5.14% | -5.46% |
| 3 Month | -2.50% | NA | -6.45% | -6.22% |
| 6 Month | -37.45% | NA | -9.28% | -8.80% |
| 1 Year | -38.63% | NA | 9.16% | 8.69% |
| 3 Year | -1.64% | NA | 37.48% | 36.97% |
Vivo Bio Tech Ltd - STOCK STRENGTH
| Today's Low/High | 38.25 |
|
40.00 |
| Week Low/High | 37.25 |
|
41.00 |
| Month Low/High | 36.70 |
|
47.00 |
| YEAR Low/High | 36.45 |
|
115.00 |
| All TIME Low/High | 1.05 |
|
115.00 |
Quick Links for Vivo Bio Tech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
